Target intelligence / Profile preview

Tyrosine-protein kinase receptors (RTKs)

Target
RTKs
Molecular classification
Receptor tyrosine kinases, Tyrosine kinase
01

Overview

Receptor tyrosine kinases (RTKs) are high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. They transmit signals from the extracellular environment to the cell interior, regulating essential cellular processes such as cell growth, proliferation, differentiation, and survival. RTKs possess a distinct structure comprising an extracellular ligand-binding domain, a transmembrane helix, and an intracellular region with a juxtamembrane region, a tyrosine kinase domain (TKD), and a C-terminal tail. Activation is typically triggered by ligand binding, leading to receptor dimerization, trans-autophosphorylation of the TKD, and subsequent recruitment and activation of downstream signaling proteins. Classified into approximately 20 families, RTKs mediate responses to diverse signals. Dysregulation of RTK signaling is heavily implicated in various diseases, particularly cancer, where mutations can result in constitutive activity contributing to tumor initiation, progression, metastasis, and drug resistance. Key signaling pathways activated by RTKs include the Ras-MAP kinase, PI3K-Akt, and PLCγ pathways. Note that the provided text also references non-receptor tyrosine kinases, but the primary subject is Receptor tyrosine kinases.

Other names
Receptor tyrosine kinases
02

Biological functions

Signal transductionCell growthCell proliferationCell differentiationDevelopmentAngiogenesisCell survivalMetabolism
03

Disease associations

Cancer (Dysregulation, Tumor transformation, Proliferation, Metastasis, Drug resistance, Angiogenesis)Other diseases (due to dysregulation)

Beyond the preview

Go deeper on Tyrosine-protein kinase receptors (RTKs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein kinase receptors (RTKs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call